A Novel EPO Receptor Agonist Improves Glucose Tolerance via Glucose Uptake in Skeletal Muscle in a Mouse Model of Diabetes

Patients treated with recombinant human Epo demonstrate an improvement in insulin sensitivity. We aimed to investigate whether CNTO 530, a novel Epo receptor agonist, could affect glucose tolerance and insulin sensitivity. A single administration of CNTO 530 significantly and dose-dependently reduce...

Descripción completa

Detalles Bibliográficos
Autores principales: Scully, Michael S., Ort, Tatiana A., James, Ian E., Bugelski, Peter J., Makropoulos, Dorie A., Deutsch, Heather A., Pieterman, Elsbet J., van den Hoek, Anita M., Havekes, Louis M., duBell, William H., Wertheimer, Joshua D., Picha, Kristen M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132469/
https://www.ncbi.nlm.nih.gov/pubmed/21754921
http://dx.doi.org/10.1155/2011/910159

Ejemplares similares

Ejemplares similares